Mandate

Vinge advises Wilson Therapeutics in connection with the offer from Alexion

April 11, 2018

Alexion has announced a public cash offer to the shareholders of Wilson Therapeutics AB.


The offer values Wilson Therapeutics at approximately SEK 6,564 million. 
 
Vinge advises Wilson Therapeutics in connection with the offer. Vinge’s team is primarily composed of Erik Sjöman, Christian Lindhé, Astrid Karlsson and Philip Åberg. 

Related

Vinge has assisted PulPac in connection with it obtaining a €20 million financing from the European Investment Bank

Vinge has assisted Gothenburg-based sustainable packaging technology company PulPac in connection with it obtaining a €20 million (around 220 million Swedish kronor) financing from the European Investment Bank (EIB).
July 18, 2025

Vinge has advised Behold Ventures in the fundraising of Behold Ventures’ first-time fund

Behold Ventures held its final closing on 27 June 2025, thereby securing investor commitments to its first-time fund amounting to approximately SEK 550 million from an international investor base, comprising the European Investment Fund (EIF), among others.
July 10, 2025

Vinge advises Main Capital in connection with the sale of Alfa eCare

Vinge has advised Main Capital in connection with the sale of Alfa eCare Holding AB and its subsidiaries (“Alfa eCare”) to SDB Groep B.V. (“SDB”)
July 10, 2025